GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Evolva Holding SA (XSWX:EVE) » Definitions » 3-Year Revenue Growth Rate

Evolva Holding (XSWX:EVE) 3-Year Revenue Growth Rate : -1.20% (As of Jun. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Evolva Holding 3-Year Revenue Growth Rate?

Evolva Holding's Revenue per Share for the six months ended in Jun. 2023 was CHF0.98.

During the past 12 months, Evolva Holding's average Revenue per Share Growth Rate was -9.50% per year. During the past 3 years, the average Revenue per Share Growth Rate was -1.20% per year. During the past 5 years, the average Revenue per Share Growth Rate was -1.20% per year. During the past 10 years, the average Revenue per Share Growth Rate was -10.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Evolva Holding was 157.50% per year. The lowest was -49.00% per year. And the median was -13.80% per year.

Competitive Comparison of Evolva Holding's 3-Year Revenue Growth Rate

For the Biotechnology subindustry, Evolva Holding's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Evolva Holding's 3-Year Revenue Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Evolva Holding's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Evolva Holding's 3-Year Revenue Growth Rate falls into.


Evolva Holding 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Evolva Holding  (XSWX:EVE) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Evolva Holding 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Evolva Holding's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Evolva Holding (XSWX:EVE) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Evolva Holding SA (XSWX:EVE) » Definitions » 3-Year Revenue Growth Rate
Comparable Companies
XSWX:KNRS XSWX:SPEX XSWX:ADXN XSWX:RLF OCSE:NOVO B VRTX REGN ASX:CSL XKRX:207940 MRNA XKRX:068270 XBRU:ARGX XBRU:UCB BNTX OCSE:GMAB ALNY BGNE BMRN SZSE:300122 RPRX
Traded in Other Exchanges
ELVAF:USA EVEz:UK
Address
Duggingerstrasse 23, Reinach, CHE, CH-4153
Website
https://www.evolva.com
Evolva Holding SA en liquidation formerly Evolva Holding SA is a biotechnology company. The company is engaged in discovering, developing, and commercializing ingredients and biomanufacturing processes for nutrition, healthcare, and wellness products. Geographically, the company operates in Switzerland and the United States where Switzerland derives a majority of its revenue.